Bailly B - Search Results

1

Targeting human respiratory syncytial virus transcription anti-termination factor M2-1 to inhibit in vivo viral replication.

Bailly B, Richard CA, Sharma G, Wang L, Johansen L, Cao J, Pendharkar V, Sharma DC, Galloux M, Wang Y, Cui R, Zou G, Guillon P, von Itzstein M, Eléouët JF, Altmeyer R. Bailly B, et al. Sci Rep. 2016 May 19;6:25806. doi: 10.1038/srep25806. Sci Rep. 2016. PMID: 27194388 Free PMC article.

2

Structure-guided discovery of potent and dual-acting human parainfluenza virus haemagglutinin-neuraminidase inhibitors.

Guillon P, Dirr L, El-Deeb IM, Winger M, Bailly B, Haselhorst T, Dyason JC, von Itzstein M. Guillon P, et al. Among authors: bailly b. Nat Commun. 2014 Oct 20;5:5268. doi: 10.1038/ncomms6268. Nat Commun. 2014. PMID: 25327774 Free article.

3

The approved pediatric drug suramin identified as a clinical candidate for the treatment of EV71 infection-suramin inhibits EV71 infection in vitro and in vivo.

Ren P, Zou G, Bailly B, Xu S, Zeng M, Chen X, Shen L, Zhang Y, Guillon P, Arenzana-Seisdedos F, Buchy P, Li J, von Itzstein M, Li Q, Altmeyer R. Ren P, et al. Among authors: bailly b. Emerg Microbes Infect. 2014 Sep;3(9):e62. doi: 10.1038/emi.2014.60. Epub 2014 Sep 3. Emerg Microbes Infect. 2014. PMID: 26038755 Free PMC article.

4

A dual drug regimen synergistically blocks human parainfluenza virus infection.

Bailly B, Dirr L, El-Deeb IM, Altmeyer R, Guillon P, von Itzstein M. Bailly B, et al. Sci Rep. 2016 Apr 7;6:24138. doi: 10.1038/srep24138. Sci Rep. 2016. PMID: 27053240 Free PMC article.

5

A sialosyl sulfonate as a potent inhibitor of influenza virus replication.

Hadházi Á, Pascolutti M, Bailly B, Dyason JC, Borbás A, Thomson RJ, von Itzstein M. Hadházi Á, et al. Among authors: bailly b. Org Biomol Chem. 2017 Jun 27;15(25):5249-5253. doi: 10.1039/c7ob00947j. Org Biomol Chem. 2017. PMID: 28540971

6

A Sulfonozanamivir Analogue Has Potent Anti-influenza Virus Activity.

Hadházi Á, Li L, Bailly B, Maggioni A, Martin G, Dirr L, Dyason JC, Thomson RJ, Gao GF, Borbás A, Ve T, Pascolutti M, von Itzstein M. Hadházi Á, et al. Among authors: bailly b. ChemMedChem. 2018 Apr 23;13(8):785-789. doi: 10.1002/cmdc.201800092. Epub 2018 Mar 15. ChemMedChem. 2018. PMID: 29453852

7

New antiviral approaches for human parainfluenza: Inhibiting the haemagglutinin-neuraminidase.

Chibanga VP, Dirr L, Guillon P, El-Deeb IM, Bailly B, Thomson RJ, von Itzstein M. Chibanga VP, et al. Among authors: bailly b. Antiviral Res. 2019 Jul;167:89-97. doi: 10.1016/j.antiviral.2019.04.001. Epub 2019 Apr 3. Antiviral Res. 2019. PMID: 30951732 Review.

8

Efficient Blocking of Enterovirus 71 Infection by Heparan Sulfate Analogues Acting as Decoy Receptors.

Earley DF, Bailly B, Maggioni A, Kundur AR, Thomson RJ, Chang CW, von Itzstein M. Earley DF, et al. Among authors: bailly b. ACS Infect Dis. 2019 Oct 11;5(10):1708-1717. doi: 10.1021/acsinfecdis.9b00070. Epub 2019 Aug 5. ACS Infect Dis. 2019. PMID: 31307190

9

Multidisciplinary Approaches Identify Compounds that Bind to Human ACE2 or SARS-CoV-2 Spike Protein as Candidates to Block SARS-CoV-2-ACE2 Receptor Interactions.

Day CJ, Bailly B, Guillon P, Dirr L, Jen FE, Spillings BL, Mak J, von Itzstein M, Haselhorst T, Jennings MP. Day CJ, et al. Among authors: bailly b. mBio. 2021 Mar 30;12(2):e03681-20. doi: 10.1128/mBio.03681-20. mBio. 2021. PMID: 33785634 Free PMC article.

10

Platinum complexes act as shielding agents against virus infection.

Bailly B, Gorle AK, Dirr L, Malde AK, Farrell NP, Berners-Price SJ, von Itzstein M. Bailly B, et al. Chem Commun (Camb). 2021 May 11;57(38):4666-4669. doi: 10.1039/d1cc01593a. Chem Commun (Camb). 2021. PMID: 33977992

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

53 results

Search Page

Filters